Annual Drug Patent Expirations for BEYAZ
Beyaz is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for BEYAZ.
This drug has one hundred and six patent family members in forty countries.
The generic ingredient in BEYAZ is drospirenone; ethinyl estradiol; levomefolate calcium. Two suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol; levomefolate calcium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
